Scholarlink

Background <p>Predictive models for recurrence following atrial fibrillation (AF) radiofrequency catheter ablation (RFCA) have potential value in minimizing the risk of recurrent atrial tachyarrhythmias (ATAs). This study aims to develop and validate models to optimize patient selection and post-ablation management.</p> Methods <p>A retrospective analysis of consecutive AF patients undergoing RFCA from January 2021 to August 2023 identified risk factors for ATAs recurrence through regression analysis, leading to the development of two predictive models, HWARNER 1 and HWARNER 2, which were preliminarily externally validated.</p> Results <p>Seven risk factors were identified: Weight &gt; 77.5&#xa0;kg, HbA1c &gt; 5.75%, RA (dimension / &gt; 46.5&#xa0;mm), NT-proBNP &gt; 650.18&#xa0;pg/ml, Early AF recurrence, Redo procedures, and Height &gt; 171.5&#xa0;cm. Based on these factors, the HWARNER models showed high predictive accuracy with AUCs of 0.775 and 0.773, outperforming established models. Kaplan–Meier analysis revealed significant differences in ATAs recurrence between low- and high-risk groups (HWARNER 1: 93.0% vs. 59.1%, <i>P</i> &lt; 0.001; HWARNER 2: 94.5% vs. 67.9%, <i>P</i> &lt; 0.001) with an median follow-up of one year. In subgroup analysis, HbA1c showed stronger predictive value in patients with BMI &gt; 26.7 (OR = 7.191, 95% CI: 1.375–37.594, <i>P</i> = 0.019). In paroxysmal AF (PAF) patients, the pulmonary vein isolation plus low voltage zones-stepwise (PVI + LVZs-Stepwise) protocol showed no benefit over PVI alone.</p> Conclusion <p>The HWARNER models have the potential to predict ATAs recurrence after RFCA, providing a valuable tool for patient selection and management. HbA1c is an important independent risk factor.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development and validation of the HWARNER models for predicting atrial tachyarrhythmias recurrence after AF ablation: a retrospective cohort study with emphasis on HbA1c

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月26日

查看全文
  • Min Xu,
  • Ruikun Jia,
  • Juan Chan,
  • Hanlin Wang,
  • Qidong Gao,
  • Sitai Liu,
  • Dayong Zhang,
  • Yunfeng Di,
  • Kaijun Cui

摘要

Background

Predictive models for recurrence following atrial fibrillation (AF) radiofrequency catheter ablation (RFCA) have potential value in minimizing the risk of recurrent atrial tachyarrhythmias (ATAs). This study aims to develop and validate models to optimize patient selection and post-ablation management.

Methods

A retrospective analysis of consecutive AF patients undergoing RFCA from January 2021 to August 2023 identified risk factors for ATAs recurrence through regression analysis, leading to the development of two predictive models, HWARNER 1 and HWARNER 2, which were preliminarily externally validated.

Results

Seven risk factors were identified: Weight > 77.5 kg, HbA1c > 5.75%, RA (dimension / > 46.5 mm), NT-proBNP > 650.18 pg/ml, Early AF recurrence, Redo procedures, and Height > 171.5 cm. Based on these factors, the HWARNER models showed high predictive accuracy with AUCs of 0.775 and 0.773, outperforming established models. Kaplan–Meier analysis revealed significant differences in ATAs recurrence between low- and high-risk groups (HWARNER 1: 93.0% vs. 59.1%, P < 0.001; HWARNER 2: 94.5% vs. 67.9%, P < 0.001) with an median follow-up of one year. In subgroup analysis, HbA1c showed stronger predictive value in patients with BMI > 26.7 (OR = 7.191, 95% CI: 1.375–37.594, P = 0.019). In paroxysmal AF (PAF) patients, the pulmonary vein isolation plus low voltage zones-stepwise (PVI + LVZs-Stepwise) protocol showed no benefit over PVI alone.

Conclusion

The HWARNER models have the potential to predict ATAs recurrence after RFCA, providing a valuable tool for patient selection and management. HbA1c is an important independent risk factor.